Display options
Share it on

Int J Clin Exp Med. 2015 Jul 15;8(7):10508-14. eCollection 2015.

Interaction between carbenoxolone and valproic acid on pentylenetetrazole kindling model of epilepsy.

International journal of clinical and experimental medicine

Fatih Sefil, Aliye E Arık, Meryem D Acar, Mehmet Ö Bostancı, Faruk Bagirici, Ramazan Kozan

Affiliations

  1. Department of Physiology, Faculty of Medicine, Mustafa Kemal University Hatay, Turkey.
  2. Department of Physiology, Faculty of Medicine, Ondokuz Mayis University Samsun, Turkey.
  3. Department of Physiology, Faculty of Medicine, Hitit University Çorum, Turkey.
  4. Department of Physiology, Faculty of Medicine, ?stanbul Medeniyet University ?stanbul, Turkey.

PMID: 26379841 PMCID: PMC4565224

Abstract

Gap junctions play an important role in the synchronized neuronal discharges. The main reason of the epileptic seizures is disruption of this synchronization. Therefore, the aim of the present study is to explore the combination valproic acid with carbenoxolone in pentylenetetrazole-kindled rats. In the first set of experiments, pentylenetetrazole (35 mg/kg intraperitoneally was administered to the rats to produce the kindling and then permanent screw electrodes to record electroencephalographic signals. The kindled rats were divided into six groups. While electroencephalographic recordings received from animals, behavioral evaluation was done by an observer. The data analysis was performed using T test and Mann-Whitney U tests. The dose of 40 mg/kg carbenoxolone was the most effective in carbenoxolone treatment groups. It prevented generalized seizures by 50%, reduced seizure stage, seizure duration and spike frequency. There was no significant difference between carbenoxolone-valproic acid combination and valproic acid on any seizure parameters. The current study is the first study which shows the interaction of carbenoxolone with valproic acid in pentylenetetrazole kindling model. As a result, carbenoxolone-valproic acid combination was not more effective than the standalone use of these drugs.

Keywords: Gap junction; carbenoxolone; epilepsy; kindling model; valproic acid

References

  1. Epilepsy Res Treat. 2010;2010:310753 - PubMed
  2. Prog Neuropsychopharmacol Biol Psychiatry. 2004 Jan;28(1):105-13 - PubMed
  3. Epilepsy Res. 2007 Jul;75(2-3):97-103 - PubMed
  4. Biomed Res Int. 2014;2014:876712 - PubMed
  5. Ann Neurol. 1991 Apr;29(4):356-63 - PubMed
  6. CNS Drugs. 2002;16(10):669-94 - PubMed
  7. Eur J Pharmacol. 1992 Nov 10;222(2-3):273-8 - PubMed
  8. Eur J Pharmacol. 1993 Apr 6;234(2-3):237-45 - PubMed
  9. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Mar 17;33(2):181-98 - PubMed
  10. Int J Neurosci. 2014 Oct;124(10):762-70 - PubMed
  11. Int J Neurosci. 2012 Apr;122(4):200-8 - PubMed
  12. Brain Res. 1992 Oct 16;593(2):329-31 - PubMed
  13. Neurochem Int. 2004 Mar;44(4):263-70 - PubMed
  14. Exp Brain Res. 2002 Oct;146(3):336-44 - PubMed
  15. Curr Opin Neurol. 2003 Apr;16(2):165-70 - PubMed
  16. Eur J Pharmacol. 2004 Jan 19;484(1):49-56 - PubMed
  17. Seizure. 2007 Mar;16(2):166-72 - PubMed
  18. Electroencephalogr Clin Neurophysiol. 1972 Mar;32(3):269-79 - PubMed
  19. Epilepsia. 2005 Oct;46(10):1581-91 - PubMed
  20. Epilepsy Res. 2011 Oct;96(3):191-206 - PubMed
  21. CNS Drug Rev. 2003 Summer;9(2):199-216 - PubMed
  22. Acta Neurobiol Exp (Wars). 2012;72(2):177-84 - PubMed
  23. Brain Dev. 1997 Apr;19(3):171-5 - PubMed
  24. Int J Neurosci. 2014 Mar;124(3):181-6 - PubMed
  25. Prog Neurobiol. 1999 May;58(1):31-59 - PubMed
  26. Epilepsia. 2009 Aug;50(8):1971-8 - PubMed
  27. BMC Pharmacol. 2003 Apr 29;3:3 - PubMed
  28. Zhongguo Dang Dai Er Ke Za Zhi. 2007 Oct;9(5):465-8 - PubMed
  29. Neurology. 2001 Nov 13;57(9):1536-42 - PubMed
  30. Int J Neurosci. 2011 Feb;121(2):69-85 - PubMed
  31. Nat Rev Neurosci. 2004 Jul;5(7):553-64 - PubMed

Publication Types